CFB
TDOC icon

Cullen/Frost Bankers’s Teladoc Health TDOC Stock Holding History

Cullen/Frost Bankers’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-27
Closed -$582 – 1092
2023
Q4 		$582 Buy
+27
New +$498 ﹤0.01% 997
2022
Q4 		– Sell
-10
Closed – – 1200
2022
Q3 		$0 Buy
+10
New +$351 ﹤0.01% 1202
2022
Q2 		– Sell
-202
Closed -$15K – 1189
2022
Q1 		$15K Sell
202
-24
-11% -$1.73K ﹤0.01% 913
2021
Q4 		$21K Hold
226
– – ﹤0.01% 892
2021
Q3 		$29K Hold
226
– – ﹤0.01% 897
2021
Q2 		$38K Buy
226
+69
+44% +$11.2K ﹤0.01% 839
2021
Q1 		$28K Sell
157
-291
-65% -$67.5K ﹤0.01% 815
2020
Q4 		$90K Buy
448
+24
+6% +$4.88K ﹤0.01% 593
2020
Q3 		$93K Sell
424
-94
-18% -$19.9K ﹤0.01% 565
2020
Q2 		$99K Buy
+518
New +$90.8K ﹤0.01% 540

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Cullen/Frost Bankers's TDOC Position: Q1 2024 in Review

Cullen/Frost Bankers sold out of Teladoc Health (TDOC) in Q1 2024, closing a stake of 27 shares — an estimated $582 sold.

Cullen/Frost Bankers first reported a position in TDOC in Q2 2020 and held it in 10 quarters. The position peaked at $99K in Q2 2020. 427 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

  • Cullen/Frost Bankers reported no remaining Teladoc Health position as of Q1 2024 after selling out during the quarter.
  • Cullen/Frost Bankers sold 27 Teladoc Health shares in Q1 2024, an estimated $582.
  • Cullen/Frost Bankers first reported a position in Teladoc Health in Q2 2020 and held it in 10 quarters.
  • Cullen/Frost Bankers's Teladoc Health position peaked at $99K in Q2 2020.
  • 427 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on Cullen/Frost Bankers's 13F filing for Q1 2024, filed 10 May 2024.